Objective: The objective of this study was todirectly assess the likelihood and timing of alphablocker discontinuation in patients receivingcombination therapy with dutasteride orfinasteride plus an ...

: To evaluate the likelihood of alphaadrenergic antagonist (alpha-blocker) discontinuation in combination with dutasteride or finasteride among patients aged =65 years with enlarged prostate. Methods ...

The aim of the present study was to evaluate the clinical efficacy and safety of PDE5-Is co-administered with an α-blocker to patients with both BPH-LUTS and ED (mirodenafil 50 mg once daily (OD) in ...

A meta-analysis evaluated the efficacy and safety of imidafenacin for overactive bladder induced by benign prostatic hyperplasia. Combining imidafenacin with an alpha-blocker may effectively treat ...

About 9,000 alpha-blocker patients had a fracture versus 3,351 matched patients on other antihypertensives; “9,000 patients out of 70,000 is a huge number. These drugs are useful in some situations, ...

Old man taking a pill New study is the largest to date assessing cardiovascular risks in patients taking alpha blockers. Men who take alpha blockers (ABs) rather than 5-alpha reductase inhibitors ...

Recent results from clinical trials on hormone therapy and treating hypertension have changed the way physicians prescribe and the way patients use certain medications, according to two studies in the ...